Artwork

Content provided by PwC's Health Industries. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by PwC's Health Industries or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Health Industries: U.S. Deals Outlook for 2025 and Beyond

25:18
 
Share
 

Manage episode 459661857 series 3305757
Content provided by PwC's Health Industries. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by PwC's Health Industries or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Tune in to listen as PwC’s leaders Roel van den Akker and Nick Donkar provide insights into the 2024 deals landscape and offer a preview of what lies ahead. Topics include:

Key topics include:

  • A look back at M&A activity in health industries in 2024
  • The challenges and potential impediments that could affect deal volumes in the coming year
  • How artificial intelligence and tech innovations are reshaping the volume and nature of healthcare transactions
  • Key trends and developments to watch for with emphasis on growth, strategic assessments and regulatory factors

Speakers:
Roel van den Akker, Pharmaceutical and Life Sciences Deals Leader, PwC
Nick Donkar, Health Services Deals Leader, PwC
Jenny Colapietro, Consulting Commercial Leader, PwC
Linked materials:

  • https://www.pwc.com/us/en/industries/health-industries/library/health-services-deals-outlook.html
  • https://www.pwc.com/us/en/industries/health-industries/library/pharma-life-sciences-deals-outlook.html

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

  continue reading

59 episodes

Artwork
iconShare
 
Manage episode 459661857 series 3305757
Content provided by PwC's Health Industries. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by PwC's Health Industries or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Tune in to listen as PwC’s leaders Roel van den Akker and Nick Donkar provide insights into the 2024 deals landscape and offer a preview of what lies ahead. Topics include:

Key topics include:

  • A look back at M&A activity in health industries in 2024
  • The challenges and potential impediments that could affect deal volumes in the coming year
  • How artificial intelligence and tech innovations are reshaping the volume and nature of healthcare transactions
  • Key trends and developments to watch for with emphasis on growth, strategic assessments and regulatory factors

Speakers:
Roel van den Akker, Pharmaceutical and Life Sciences Deals Leader, PwC
Nick Donkar, Health Services Deals Leader, PwC
Jenny Colapietro, Consulting Commercial Leader, PwC
Linked materials:

  • https://www.pwc.com/us/en/industries/health-industries/library/health-services-deals-outlook.html
  • https://www.pwc.com/us/en/industries/health-industries/library/pharma-life-sciences-deals-outlook.html

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

  continue reading

59 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Listen to this show while you explore
Play